Brief: Elicera Therapeutics Q3 Operating Loss Narrows To SEK 5.1 Million
14/11/2023 07:55
Nov 14 (Reuters) - Elicera Therapeutics AB ELIC.ST :
* Q3 OPERATING LOSS SEK 5.1 MILLION VERSUS LOSS SEK 7.0
MILLION
YEAR AGO
Source text for Eikon: ID:nWkr57nKV7
Further company coverage: ELIC.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Nomination Committee Proposes Margareth Jorvid As Chair Of Elicera Board
Brief: Elicera Therapeutics Carries Out Rights Issue Of About SEK 73 Mln
Sweden's Elicera Therapeutics Q1 loss narrows, reports positive clinical progress
Brief: Elicera Therapeutics Q1 Operating Loss SEK 5.1 Mln
Brief: Elicera Therapeutics Gets Notice Of Allowance For Japanease Patent